Effect of Astragalus Polysaccharides on Cardiac Dysfunction in dbdb Mice with Respect to Oxidant Stress

Abstract EN

Objective.

Oxidant stress plays an important role in the development of diabetic cardiomyopathy.

Previously we reported that Astragalus polysaccharides (APS) rescued heart dysfunction and cardinal pathological abnormalities in diabetic mice.

In the current study, we determined whether the effect of APS on diabetic cardiomyopathy was associated with its impact on oxidant stress.

Methods.

Db/db diabetic mice were employed and administered with APS.

The hematodynamics, cardiac ultra-structure, apoptosis, and ROS formation of myocardium were assessed.

The cardiac protein expression of apoptosis target genes (Bax, Bcl-2, and caspase-3) and oxidation target genes (Gpx, SOD2, t/p-JNK, catalase, t/p-p38 MAPK, and t/p-ERK) were evaluated, respectively.

Results.

APS therapy improved hematodynamics and cardinal ultra-structure with reduced apoptosis and ROS formation in db/db hearts.

In addition, APS therapy inhibited the protein expression of apoptosis target genes (Bax, Bcl-2, and caspase-3) and regulated the protein expression of oxidation target genes (enhancing Gpx, SOD2, and catalase, while reducing t/p-JNK, t/p-ERK, and t/p-p38 MAPK) in db/db hearts.

Conclusion.

Our findings suggest that APS has benefits in diabetic cardiomyopathy, which may be partly associated with its impact on cardiac oxidant stress.